
ASTRAZENAstrazeneca Pharma India Ltd.
Astrazeneca Pharma India to launch Datverzo breast cancer drug in November
The launch covers Datopotamab Deruxtecan, approved for certain adults with HR-positive, HER2-negative breast cancer after endocrine and chemotherapy. The price and exact launch date are not stated.
- Guidance
- Pharmaceuticals
